In The News

As the Focus on Psychedelic Stocks Increases, So Do the Valuations

Rakesh Jetly, MD: Psychedelics Show Promise Treating PTSD

Psychedelic Scientist Robin Carhart Harris Leads The Research Renaissance With Over 100 Peer-Reviewed Publications

The Migration Saga: From Beverage to Cannabis (And Vice Versa)

2020: A Year in Review for the Psychedelic Renaissance

TDR's Top 5 Psychedelic Developments for the Week of December 21

Mydecine Speaker Series: Psychedelic Solutions

Understanding The Psilocybin Supply Chain: Every Production Method Explained

Clinical trial explores psychedelic treatments for PTSD in veterans

More U.S. Military Funding for Psychedelic Drug R&D As PTSD Crisis Worsens